InsiderClue
Stocks · Health care · Pharmaceutical Preparations

LIGAND PHARMACEUTICALS INC

LGND Clue Score50
United States Fiscal year ends December CIK 0000886163 Results filed 29 Oct 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

15
Insider
Date
Role
Action
Shares
Price
Amount
Jason Aryeh
2 Nov 2026
Director
Sell
700
$320.43
$224.30K
Jason Aryeh
30 Oct 2026
Director
Sell
50
$320.49
$16.02K
Jason Aryeh
30 Oct 2026
Director
Sell
1,209
$320.42
$387.38K
Jason Aryeh
30 Oct 2026
Director
Sell
52
$320.24
$16.65K
Jason Aryeh
30 Oct 2026
Director
Sell
50
$318.23
$15.91K
Jason Aryeh
30 Oct 2026
Director
Sell
50
$317.74
$15.89K
Martine Zimmermann
10 Sep 2026
Director
Sell
1,200
$285.00
$342.00K
Jason Aryeh
11 Jun 2026
Director
Sell
4,500
$250.00
$1.13M
John L Lamattina
10 Jun 2026
Director
Sell
3,405
$251.62
$856.75K
John L Lamattina
10 Jun 2026
Director
Sell
697
$249.53
$173.92K
John L Lamattina
10 Jun 2026
Director
Sell
232
$248.11
$57.56K
John L Lamattina
10 Jun 2026
Director
Sell
257
$247.22
$63.54K
Jason Aryeh
10 Jun 2026
Director
Sell
500
$250.00
$125.00K
Stephen L Sabba
23 Mar 2026
Director
Sell
1,000
$207.87
$207.87K
Octavio Espinoza
12 Dec 2025
Chief Financial Officer
Sell
1,804
$188.31
$339.71K
Show all 154 transactions →

What was left out

Form 4 filings counted 52
Amendments (4/A) skipped 0
Filings about a different issuer 2
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 38
Sales straight out of an exercise 93
Sales at will 15
Transactions with no price 0
Shares from compensation/vesting 281,927
History held since 29 Sep 2006